Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/23996
Title: | A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference | Authors: | Kirchhof, Paulus Breithardt, Guenter Bax, Jeroen Benninger, Gerlinde Blomstrom-Lundqvist, Carina Boriani, Giuseppe Brandes, Axel Brown, Helen Brueckmann, Martina Calkins, Hugh Calvert, Melanie Christoffels, Vincent Crijns, Harry Dobrev, Dobromir Ellinor, Patrick Fabritz, Larissa Fetsch, Thomas Freedman, S. Ben Gerth, Andrea Goette, Andreas Guasch, Eduard Hack, Guido Haegeli, Laurent Hatem, Stephane Haeusler, Karl Georg HEIDBUCHEL, Hein Heinrich-Nols, Jutta Hidden-Lucet, Francoise Hindricks, Gerd Juul-Moeller, Steen Kaeaeb, Stefan Kappenberger, Lukas Kespohl, Stefanie Kotecha, Dipak Lane, Deirdre A. Leute, Angelika Lewalter, Thorsten Meyer, Ralf Mont, Lluis Muenzel, Felix Nabauer, Michael Nielsen, Jens C. Oeff, Michael Oldgren, Jonas Oto, Ali Piccini, Jonathan P. Pilmeyer, Art Potpara, Tatjana Ravens, Ursula Reinecke, Holger Rostock, Thomas Rustige, Joerg Savelieva, Irene Schnabel, Renate Schotten, Ulrich Schwichtenberg, Lars Sinner, Moritz F. Steinbeck, Gerhard Stoll, Monika Tavazzi, Luigi Themistoclakis, Sakis Tse, Hung Fat Van Gelder, Isabelle C. Vardas, Panagiotis E. Varpula, Timo Vincent, Alphons Werring, David Willems, Stephan Ziegler, Andre Lip, Gregory Y. H. Camm, A. John |
Issue Date: | 2016 | Source: | EUROPACE, 18(1), p. 37-50 | Abstract: | At least 30 million people worldwide carry a diagnosis of atrial fibrillation (AF), and many more suffer from undiagnosed, subclinical, or 'silent' AF. Atrial fibrillation-related cardiovascular mortality and morbidity, including cardiovascular deaths, heart failure, stroke, and hospitalizations, remain unacceptably high, even when evidence-based therapies such as anticoagulation and rate control are used. Furthermore, it is still necessary to define how best to prevent AF, largely due to a lack of clinical measures that would allow identification of treatable causes of AF in any given patient. Hence, there are important unmet clinical and research needs in the evaluation and management of AF patients. The ensuing needs and opportunities for improving the quality of AF care were discussed during the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference in Nice, France, on 22 and 23 January 2015. Here, we report the outcome of this conference, with a focus on (i) learning from our 'neighbours' to improve AF care, (ii) patient-centred approaches to AF management, (iii) structured care of AF patients, (iv) improving the quality of AF treatment, and (v) personalization of AF management. This report ends with a list of priorities for research in AF patients. | Keywords: | atrial fibrillation; outcomes; quality of care; research; rate control; antiarrhythmic drugs; catheter ablation; anticoagulation; cardiovascular risk; bleeding; research priorities | Document URI: | http://hdl.handle.net/1942/23996 | ISSN: | 1099-5129 | e-ISSN: | 1532-2092 | DOI: | 10.1093/europace/euv304 | ISI #: | 000370982800005 | Rights: | (c) Published on behalf of the European Society of Cardiology. All rights reserved. & The Author 2015. | Category: | A1 | Type: | Journal Contribution | Validations: | ecoom 2017 |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
euv304.pdf | Published version | 291.58 kB | Adobe PDF | View/Open |
SCOPUSTM
Citations
79
checked on Sep 3, 2020
WEB OF SCIENCETM
Citations
105
checked on Aug 11, 2024
Page view(s)
54
checked on Aug 10, 2022
Download(s)
78
checked on Aug 10, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.